Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-19 | Mr. Burns has more than 25 years of direct ophthalmic management experience and received a B.A. from Yale University. |
| 2017-04-18 | Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices, ophthalmic pharmaceuticals, drug delivery technologies, surgical products and over-the-counter products. Mr. Burns received a B.A. from Yale University. |
| 2018-04-18 | Mr. Burns has a proven record of building successful medical device and pharmaceutical businesses and creating successful new markets in ophthalmology. Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices, ophthalmic pharmaceuticals, drug delivery technologies, surgical products and over-the-counter products. Prior to joining our Company, Mr. Burns led Eyetech Pharmaceuticals, Inc. (acquired by OSI Pharmaceuticals, Inc.) as its president and chief operating officer, and as a director. |
| 2019-04-17 | Mr. Burns received a B.A. from Yale University. |
| 2020-04-24 | Mr. Burns received a B.A. from Yale University. We believe Mr. Burns’ extensive understanding of our business, operations and strategy, as well as significant industry experience and corporate management skills and experience, qualify him to serve on our Board of Directors. |
| 2021-04-22 | Mr. Burns has more than 25 years of direct ophthalmic management experience, including over 20 years of general management experience across a broad range of ophthalmic medical devices and pharmaceuticals, drug delivery technologies, surgical products and over-the-counter products. |
| 2022-04-19 | Mr. Burns has more than 25 years of direct ophthalmic management experience ... Mr. Burns received a B.A. from Yale University. |
| 2023-04-18 | Chief Executive Officer and Board Member, Glaukos Corporation (2002 to current); Chairman of the Board (2021 to current); Bachelor of Arts, Yale University; no mention of technical or software skills. |
| 2024-04-16 | Chief Executive Officer and Board Member, Glaukos Corporation (2002 to current); Chairman of the Board (2021 to current); Bachelor of Arts, Yale University; Proven record of building successful medical device and pharmaceutical businesses. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-09 | Mr. Burns holds a B.A. from Yale University. |
| 2022-04-15 | Since December 2021, Mr. Burns has served as Chairman of the Board and Chief Executive Officer of Glaukos Corporation, a medical technology and pharmaceutical company. Mr. Burns holds a B.A. from Yale University. |
| 2023-04-04 | Mr. Burns holds a B.A. from Yale University. We believe that Mr. Burns is qualified to serve as a member of our Board because of his extensive leadership and management experience in the medical technology industry and his experience on private and public company boards. |
| 2024-04-05 | Mr. Burns holds a B.A. from Yale University. |
| 2025-04-08 | Mr. Burns holds a B.A. from Yale University. We believe that Mr. Burns is qualified to serve as a member of our Board because of his extensive leadership and management experience in the medical technology industry and his experience on private and public company boards. |
Data sourced from SEC filings. Last updated: 2026-02-03